Tuberculosis is a daunting problem that disproportionately affects those living in poverty, and it is the leading cause of death from infectious disease worldwide. In 2016, an estimated 10.4 million new cases were reported – nearly 1 million of these were children living in the poorest countries – and nearly 1.7 million people died from the disease. The current drugs take too long to work, have many side effects, are very costly, and there is also a growing urgency due to numerous strains resistant to current medications. New medicines are desperately needed. At Lgenia, we exist to focus on this problem, and we believe that the best new medicines begin their trek to these patients right at the very start of discovery – they begin with Lgenia – the essence of lead generation…
| Website | http://lgenia.com |
| Employees | 10 (8 on RocketReach) |
| Founded | 2018 |
| Address | S Maple St, Fortville, Indiana 46040, US |
| Technologies |
HTML
,
PHP
,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Tuberculosis Research, Global Health, Infectious Disease Treatment, Global Health Solutions, Drug Discovery, Pharmaceutical Development, Vaccine Development, Pharmaceutical Research, Biotechnology, Clinical Trials, Public Health Initiatives, Disease Prevention, Medical Research, Healthcare Innovation, Epidemic Control, Health Technology, Infection Control, Immunology |
| Competitors | Ubisoft Montréal, Tencent, Epic Games, Zynga, Unity, Activision, Riot Games, Gameloft, Supercell, NetEase Games +39 more (view full list) |
Looking for a particular Lgenia employee's phone or email?
Philip Hipskind is the CEO, CSO, Founder of Lgenia.
8 people are employed at Lgenia.
Lgenia is based in Fortville, Indiana.